Cancer BiologybioRxivPreprint
TRIM24 Degradation Counteracts Adaptation to Androgen Receptor Inhibition in Prostate Cancer
Daniela Bossi, Arianna Vallerga, Giuseppe Salfi…·Jean-Philippe Paul. Theurillat
This study identifies TRIM24 as a target for preventing prostate cancer progression by degrading it to counteract AR inhibition adaptation and tumor relapse.
DOI 10.1101/2025.08.21.671529